
The future is here: an e-commerce and gaming giant teamed up with an Artificial Intelligence (AI) startup in Japan to create an innovative, promising solution to identify – and fight – cancer using QIAGEN's QIAseq Kits for next-generation sequencing.
“Just knowing you have cancer is not enough for treatment. You need to know where. We, therefore, want to develop a pan-cancer screening assay.”
Dr. Kiyo Ishikura, Associate Director of healthcare, PFDeNA
“We believe machine learning and deep learning brings much higher sensitivity and specificity than conventional assays for cancer screening.”
Dr. Kiyo Ishikura, Associate Director of healthcare, PFDeNA
“QIAGEN is a vital, reliable partner in our work and has provided us with high-quality, cutting-edge reagents and ensured a stable supply.”
Tatsuya Yamaguchi, head of lab operations, PFDeNA
Explore innovative QIAseq solutions for your NGS workflows
Achieve effective rRNA removal from mammalian RNA-seq samples for maximum gene expression reads
More content
Related products
-
QIAamp DNA Blood Mini Kit
Optimized reaction Chemistry
QIAamp kits for extracting DNA from human tissue/blood and other body fluids, with dedicated kits for many sample types
-
miRNeasy Serum/Plasma Kit
High-purity RNA from minimal elution volume
Easy and robust purification of cell-free total RNA, including miRNA, from small volumes of animal and human plasma and serum.
-
QIAseq miRNA Library QC PCR Panel and Assays
Essential for challenging samples
For evaluating RNA sample quality prior to miRNA/small RNA NGS library preparation and for assessing NGS performance post-sequencing.